The best indicator for Labcorp (LH)
We backtested 20 indicators across daily, weekly and hourly charts on real Labcorp (LH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Labcorp (LH) over ~36.2 years — beating buy-and-hold by 1.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 50/200 Cross ✓ | Daily | 8.4% | 0.45 | -65.6% | 58.3% | 24 | 1.3% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 7.2% | 0.42 | -61.5% | 53.3% | 15 | 0.4% |
| 3 | Donchian Breakout ✓ | Weekly | 4.8% | 0.34 | -65.8% | 31.0% | 29 | -2.0% |
| 4 | Bollinger Breakout | Weekly | 3.8% | 0.31 | -48.1% | 51.6% | 31 | -3.0% |
| 5 | RSI Mean-Reversion ✓ | Daily | 3.8% | 0.3 | -36.0% | 80.0% | 50 | -3.3% |
| 6 | Stochastic ✓ | Weekly | 4.1% | 0.3 | -76.9% | 76.9% | 39 | -2.6% |
| 7 | EMA 50/200 Cross ✓ | Daily | 4.0% | 0.29 | -78.6% | 41.7% | 24 | -3.1% |
| 8 | CCI ✓ | Daily | 4.2% | 0.29 | -71.1% | 71.6% | 176 | -2.9% |
| 9 | WaveTrend (8/6/4) ✓ | Daily | 4.3% | 0.29 | -82.8% | 66.4% | 134 | -2.9% |
| 10 | CCI ✓ | Weekly | 3.1% | 0.26 | -75.0% | 77.8% | 36 | -3.7% |
| 11 | Heikin-Ashi Trend ✓ | Weekly | 3.0% | 0.25 | -78.4% | 50.0% | 334 | -3.7% |
| 12 | Holy Grail Confluence ✓ | Daily | 2.7% | 0.24 | -73.6% | 78.8% | 52 | -4.4% |
| 13 | RSI Trend (>50) ✓ | Weekly | 2.9% | 0.24 | -60.5% | 48.6% | 105 | -3.9% |
| 14 | Bollinger Mean-Reversion ✓ | Weekly | 2.9% | 0.24 | -77.6% | 77.4% | 31 | -3.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Labcorp (LH), SMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.